The global cellular health screening market was valued at USD 2.78 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030. During this period, the significance of precision medicine is expected to rise, particularly with the growing need to analyze biomarkers related to aging and overall cellular health. Cellular health screening is...